About the Program
This PEG focuses on elucidating the structural biology and function of lactosaminyl glycans in hematopoiesis. This effort is inspired by an overarching clinical goal: to improve therapeutic outcomes for patients with myelosuppressive conditions, marrow failure states, or myeloproliferative disorders by glycan engineering of hematopoietic progenitor cells. We aim to address clinically relevant problems by employing glycoscience-based approaches, thereby translating discoveries into new diagnostic and clinical applications. Additionally, this PEG expressly seeks to develop future generations of “translational glycobiologists” who can seamlessly work at the interface of glycoscience inquiry and medical necessity.
A series of lectures are available on YouTube that provide information relevant to research efforts of the PEG. These lectures describe how glycans orchestrate both cell migration and cell development.
- Renata Grozovsky receives Mary Rodes Gibson Memorial Award in Hemostasis and Thrombosis at ASH!
- Registration open for Charles Warren Tutorial 2013
- BWH/Harvard PEG collaborates in launching European Science Foundation Euroglycoforum Lecture Series
- BWH/Harvard PEG lectures on YouTube
- Clinical Trial to be launched
- Projects 1 and 3 – US Patent application filed – PCT/US2012/38462
- Projects 1 and 3 – US Patent Application filed
- Project 2 – US Patent application filed
- UNH-Glycomics Center hosts a training retreat
- Project 1 & 3 – US Patent application filed – 13/474,679